Show Summary Details
Page of

Current status of oral antiplatelet therapies 

Current status of oral antiplatelet therapies
Current status of oral antiplatelet therapies

Alex Hobson

and Nick Curzen

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 01 December 2020

This chapter summarizes the current guidelines for antiplatelet drugs in the context of percutaneous coronary intervention (PCI); medications at our disposal, and we will attempt to answer these questions using the evidence that is currently available. We highlight some of these issues by discussing our management of a complex clinical case. In addition we will consider to what extent technologies, pharmaceuticals, and management strategies may alter in the near future.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.